Skip to main content
Mayinglong Pharmaceutical Group Co.,Ltd logo

Mayinglong Pharmaceutical Group Co.,Ltd — Investor Relations & Filings

Ticker · 600993 ISIN · CNE000001HN2 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 931 across all filing types
Latest filing 2021-08-20 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 600993

About Mayinglong Pharmaceutical Group Co.,Ltd

https://www.mayinglong.cn/

Mayinglong Pharmaceutical Group Co.,Ltd. is a long-established enterprise specializing in the research, development, and production of Traditional Chinese Medicine (TCM). Founded in 1582, the company is widely recognized for its expertise in proctology, maintaining a dominant market position with its signature hemorrhoid ointments and suppositories. Its product portfolio also includes ophthalmic preparations, dermatological treatments, and gastrointestinal medicines. The company integrates traditional medicinal formulas with modern manufacturing technologies to provide healthcare solutions. Beyond pharmaceuticals, Mayinglong has expanded into healthcare services, including specialized hospitals and personal care products, focusing on the integration of clinical treatment and health management.

Recent filings

Filing Released Lang Actions
马应龙关于聘任高级管理人员的公告
Board/Management Information Classification · 100% confidence The document is an announcement from the company 马应龙药业集团股份有限公司 regarding the appointment of a senior management personnel, 刘平安, as the company's vice general manager. It includes details about the board meeting approving the appointment, the qualifications of the appointee, and compliance with relevant laws and regulations. There is no financial data, no mention of a report or financial results, and the content focuses solely on management changes. Therefore, this fits the category of Board/Management Information (MANG). The document length is short and it is not a report or announcement of a report publication, so it is not RPA or RNS.
2021-08-20 Chinese
马应龙2021年半年度报告
Interim / Quarterly Report Classification · 95% confidence The document is titled '2021 年半年度报告' which translates to '2021 Semi-Annual Report'. It covers the period from January 1, 2021 to June 30, 2021, indicating it is a report for a period shorter than a full fiscal year. The content includes detailed financial data such as revenue, net profit, cash flow, asset and liability analysis, management discussion and analysis, and other comprehensive financial and operational information. The length of the document is about 15,000 characters, which is substantial and contains actual financial statements and analysis. This matches the definition of an Interim / Quarterly Report (IR). It is not an announcement or a brief summary, nor is it a full annual report (10-K). Therefore, the correct classification is IR with high confidence. H1 2021
2021-08-20 Chinese
马应龙独立董事关于公司聘任高级管理人员的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from independent directors regarding the appointment of a senior management member, specifically the appointment of Mr. Liu Ping'an as Vice General Manager. It references regulatory guidelines and company bylaws related to governance and appointment procedures. The content is focused on management appointment and does not contain financial data, audit information, or other report types. Therefore, it fits the category of Board/Management Information (MANG), which covers announcements of changes in senior management.
2021-08-20 Chinese
马应龙2021年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a "2021 年半年度报告摘要" which translates to "2021 Half-Year Report Summary." It contains detailed financial data for the half-year period, including assets, liabilities, income, profit, cash flow, and operational analysis. The document includes sections such as "经营情况的讨论与分析" (Management Discussion and Analysis), financial data tables, shareholder information, and notes on changes in financial items. The length is over 6,000 characters, indicating it is a substantive report rather than a brief announcement. The content and structure align with an Interim / Quarterly Report, which covers a period shorter than a full fiscal year and includes actual financial statements and analysis. Therefore, the document is best classified as an Interim / Quarterly Report (IR). H1 2021
2021-08-20 Chinese
马应龙第十届董事会第十二次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement from the board of directors of 马应龙药业集团股份有限公司 regarding the resolutions passed at the 12th meeting of the 10th board. It includes approval of the 2021 semi-annual report and the appointment of a senior management member. The document is short (774 characters) and primarily serves as a notice of board decisions rather than containing the full semi-annual report or detailed financial data. It also references a separate announcement for the appointment of the senior manager. This fits the category of Board/Management Information (MANG) because it announces changes in senior management and board resolutions. It is not the full interim report (IR) itself, nor is it a report publication announcement (RPA) since it contains substantive board decisions. Therefore, the classification is MANG with high confidence.
2021-08-20 Chinese
马应龙2020年年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is titled as an announcement regarding the implementation of the 2020 annual equity distribution (dividend payment) by the company 马应龙药业集团股份有限公司. It details the dividend per share, relevant dates for record, ex-dividend, and payment, the approval of the distribution plan at the 2021 shareholders meeting, and tax withholding information. There are no financial statements or comprehensive financial data presented, only dividend distribution details. This matches the definition of a Notice of Dividend Amount (DIV), which announces dividend amounts, payment dates, and related shareholder information.
2021-07-06 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.